LAUSR

favoured treatments for psoriasis in Denmark and in a survey among Danish dermatologists and general practitioners (by LEO Pharma), it was indicated that vitamin D analogues were the most frequently used treatment for newly diagnosed patients and for patients receiving prolonged topical treatment. In summary, we report a detailed list of topical and systemic non-biologic treatments used by Danish patients with psoriasis prior to initiating biologic treatment. In these patients, potent corticosteroids and vitamin D analogues are the most widely used topical agents and methotrexate the most widely used systemic non-biologic agent. The work was funded by Robert Wehnerts og Kirsten Wehnerts Fonden and the Novo Nordisk Foundation (NNF15OC0017622). Dr. Skov has received consultancy and/or speaker honoraria from AbbVie, Pfizer, Janssen-Cilag, Merck Sharp & Dohme, and Leo Pharma and is a member of the advisory boards of AbbVie, Pfizer, Leo Pharma, Janssen-Cilag, Merck Sharp & Dohme, Eli Lilly, Celgene and Novartis.